Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2002
06/13/2002US20020072586 Chiral peptide nucleic acids
06/13/2002US20020072536 Novel benzimidazole derivatives
06/13/2002US20020072521 For therapy of central nervous system disorders such as stress, anxiety, depression, cardiovascular disorders, and eating disorders
06/13/2002US20020072520 For use in therapy of hyperlipidemia and arteriosclerotic disorders
06/13/2002US20020072519 Useful as psychotherapeutic agents
06/13/2002US20020072517 Substituted cyclic amine metalloprotease inhibitors
06/13/2002US20020072081 Geranylgeranyl transferase inhibitor screening assay
06/13/2002US20020071874 Compositions containing therapeutically active components having enhanced solubility
06/13/2002CA2431166A1 Indazolyl-substituted pyrroline compounds as kinase inhibitors
06/13/2002CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002CA2430683A1 Delta 1-pyrrolines
06/13/2002CA2430376A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
06/13/2002CA2429728A1 Tyrosine kinase inhibitors
06/13/2002CA2429258A1 Piperidine/piperazine-type inhibitors of p38 kinase
06/12/2002EP1212320A2 Phenylpiperazines as serotonin reuptake inhibitors
06/12/2002EP1212318A1 Substituted indolinones as tyrosine kinase inhibitors
06/12/2002EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
06/12/2002EP1212306A2 Hydroxyalkanoylaminolactams and related structures as inhibitors of abeta protein production
06/12/2002EP1212297A1 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same
06/12/2002EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
06/12/2002EP1023287B1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors
06/12/2002EP0934080B1 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
06/12/2002EP0880533B1 Triazole derivatives useful in therapy
06/12/2002EP0873320B1 Piperazine derivatives as tachykinin antagonists
06/12/2002EP0776324B1 Endothelin antagonists
06/12/2002EP0757986B1 Arylpiperidine and arylpiperazine derivatives and drugs containing the same
06/12/2002EP0688211B1 Thalidomide for inhibition of angiogenesis
06/12/2002CN1353706A Integrin receptor ligands
06/12/2002CN1353697A 4-phenyl-pyrimidine derivatives
06/12/2002CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof
06/12/2002CN1353605A Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and use thereof
06/11/2002US6404433 Data-driven layout engine
06/11/2002US6403794 Reacting a biguanidine with an alkoxycarbonyl, or a substituted triazine with ammonia or an alkylamine
06/11/2002US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith
06/11/2002US6403763 Chiral peptide nucleic acids which hybridize strongly with complementary nucleic acids; antigene and antisense agents; tools in molecular biology
06/11/2002US6403632 Cyclic amide derivative
06/11/2002US6403626 Benzimidazole derivatives
06/11/2002US6403620 Inhibitors of factor Xa with a neutral P1 specificity group
06/11/2002US6403595 Anticoagulants
06/11/2002US6403593 Triazole compounds and the use thereof
06/11/2002US6403592 Serotonin reuptake inhibitors
06/11/2002US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and
06/11/2002US6403582 Psychological disorders, antiinflammatory agents, gastrointestinal disorders
06/11/2002US6403577 Hexamethyleneiminyl tachykinin receptor antagonists
06/11/2002US6403532 Herbicidal synergistic composition, and method of controlling weeds
06/11/2002CA2240777C Triazole derivatives useful in therapy
06/06/2002WO2002044173A2 Herbicidal heterocycles
06/06/2002WO2002044168A2 Indole-type inhibitors of p38 kinase
06/06/2002WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
06/06/2002WO2002044149A1 Indole and dihydroindole derivatives
06/06/2002WO2002044145A1 New mandelic acid derivatives and their use as throbin inhibitors
06/06/2002WO2002044141A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/06/2002WO2002043667A2 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
06/06/2002WO2002024665A8 Arylalkane-sulfonamides having endothelin-antagonist activity
06/06/2002WO2002012198A3 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
06/06/2002WO2001098296A3 2-(3,5-disubstituted-4-pyridyl)-4-(thienyl, thiazolyl or arylphenyl)-1,3-oxazoline compounds
06/06/2002WO2001093841A3 Barbituric acid analogs as therapeutic agents
06/06/2002WO2001090068A3 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
06/06/2002WO2001087849A3 Modulators of tnf- alpha signaling
06/06/2002WO2001068614A3 5-substituted arylpyrimidines
06/06/2002US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives
06/06/2002US20020068735 Progesterone receptor antagonist; inhibiting breast, uterine, ovarian, endometrial, or prostate cancer
06/06/2002US20020068734 Nitrogen-containing heterocyclic compounds
06/06/2002DE10060412A1 DELTA1-Pyrroline DELTA1-pyrrolines
06/06/2002CA2429382A1 Indole-type inhibitors of p38 kinase
06/06/2002CA2427255A1 Hydrolysis of [r(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta. -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide
06/06/2002CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/05/2002EP1211313A2 Modulation of PDE11A activity
06/05/2002EP1211249A1 Novel thiazine or pyrazine derivatives
06/05/2002EP1211247A1 Acylamino cyclopropane derivatives
06/05/2002EP1211246A1 Pyrimidine derivatives and herbicides containing the same
06/05/2002EP1210344A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
06/05/2002EP1210339A1 Benzoic acid derivatives for the treatment of diabetes mellitus
06/05/2002EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
06/05/2002EP1210333A2 Novel herbicides
06/05/2002EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands
06/05/2002EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands
06/05/2002EP1023273B1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5ht1a receptors
06/04/2002USRE37729 Useful as antipsychotic and analgesic agents.
06/04/2002US6399773 Autoimmune disease; transplanting organs
06/04/2002US6399631 Carbazole neuropeptide Y5 antagonists
06/04/2002US6399603 Therapeutic heterocycles
06/04/2002US6399602 Anticancer agents
06/04/2002US6399598 Diheterocyclic metalloprotease inhibitors
06/04/2002CA2364108A1 Acylamino cyclopropane derivatives
06/04/2002CA2248366C Quinoxalinediones
06/04/2002CA2067929C Piperazine derivatives
05/2002
05/30/2002WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
05/30/2002WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase
05/30/2002WO2002042281A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers
05/30/2002WO2002042277A1 Novel compounds for use as hiv protease inhibitors
05/30/2002WO2002042273A2 Acid derivatives useful as serine protease inhibitors
05/30/2002WO2002042268A2 Ep4 receptor selective agonists in the treatment of osteoporosis
05/30/2002WO2002041910A2 Methods and compositions for the treatment of diseases of the eye
05/30/2002WO2002041889A2 Indolsulfonyl compounds useful in the treatment of cns disorders
05/30/2002WO2002041843A2 Antiinflammation agents
05/30/2002WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
05/30/2002WO2000066581A8 Cyanopyrroles as progesterone receptor agonists
05/30/2002US20020065422 Fluorescent maleimides and uses thereof
05/30/2002US20020065419 Cyclobutenedione compounds